Viridian (VRDN) Q3 2026 Earnings Call Transcript
First full quarter of Lumvoa sales beat expectations as patient starts accelerated.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
First full quarter of Lumvoa sales beat expectations as patient starts accelerated.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Texas Instruments supplies many chips for Tesla's humanoid robots.
By the end of Q3, the Denmark-based pharmaceutical company said it had rolled out the pill form of its weight-loss drug in eight countries.
India's manufacturing sector is characterized by a significant concentration in large factories generating substantial output.
Huntington's gene therapy heads toward FDA review with a launch plan taking shape.
Record cash flow meets a long wait for Keno Hill permit approvals.